Pfizer have developed a new treatment for diabetics - Exubera, an insulin which can be inhaled. The greatest potential advance in treatment for 80 years which could transform the lives of diabetics but it has been rejected by NICE on grounds of cost. However, it's benefits are huge. Not only will it bring an end to injections, for some up to five a day; but it will also reduce complications such as heart disease, amputation, blindness and kidney failure. Therefore, please show your support in asking NICE to reconsider its decision and to look at the overall benefits which would ultimately reduce lifecycle costs whilst improving the lives of millions.
No comments yet.join the discussion
Peter Yates, United Kingdom7 years ago
Lynne, United Kingdom7 years ago Comments: You get extra money for diagnosing diabetics, so with that money improve their quality of life
Ben, United Kingdom7 years ago Comments: What do we pay taxes for if not to improve people's lives through good health.
There are no highlights yet.